AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05931523 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress First Aid
Description: The focus of the model is ongoing monitoring of stress in personnel, wide spread training to help personnel recognize peers or subordinates who may need additional assistance, a spectrum of one-on-one interventions, and the ability to provide personnel higher levels of care when indicated.
Study NCT01085305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy
Description: Parents will be trained in interaction with their children in ways which foster non-hostility and cooperation in their children. By means of an ear-plug they will receive instruction on how to play and set limits for their child from their therapist who watches the interaction through a one-way mirror. Treatment is given until the parent masters these skill, which commonly takes 15-20 session of 1 hour.
Study NCT03968497 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Postoperative pain assessment with male investigator
Description: Postoperative pain evaluation by a male investigator by using visual analogue scale, numeric rating scale and Painmatcher®.
Study NCT01085305 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Usual treatment for behavioral disorders
Study NCT04031092 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wearable tech with feedback
Description: An armwrist device measuring physical activity level. The user will receive information about their physical activity level through their smartphone.
Study NCT04031092 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wearable tech without feedback
Description: An armwrist device measuring physical activity level, no reporting back to the user.
Study NCT01907243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: spreader flap
Description: producing of upper lateral cartilage flap as a spreader flap
Study NCT02241252 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: iPhone ECG
Description: Please see detailed description for additional information.
Study NCT03004742 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Flavonoid
Description: Flavonoid rich supplement
Study NCT03004742 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT01033058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: atorvastatin
Description: 80mg atorvastatin immediately after enrollment, emergency PCI,atorvastatin 40mg/d and other usual medication after PCI
Study NCT01033058 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: atorvastatin
Description: No loading dose of statin after enrollment, emergency PCI, atorvastatin 20mg/d and other usual medication after PCI
Study NCT02445508 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevelamer
Study NCT02445508 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cholecystokinin
Study NCT02445508 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevelamer placebo
Study NCT02445508 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sevelamer placebo
Study NCT02445508 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline
Study NCT02445508 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isotonic saline
Study NCT04152473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proglumide
Description: oral CCK receptor antagonist
Study NCT04420442 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scar Transformation Group
Description: Surgical excision of the NSSI scars followed by IntegraTM transplantation and wound closure with a negative pressure wound system. After 21 days the silicone layer of the IntegraTM will be removed and split thickness skin will be transplanted. After suture removal a compression therapy by individually tailored garments will be started for 12 months.
Study NCT03397537 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Letrozole 2.5Mg Tablet
Description: letrozole 2.5mg p.o.qd
Study NCT03397537 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5Mg Tablet
Description: letrozole 2.5mg p.o.qd
Study NCT03397537 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GnRH analogue
Description: 3.75 mg triptorelin im. q28d
Study NCT01418170 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: cervical spinal manipulative therapy
Description: A real cervical spine manipulation will be used for the intervention vs a sham cervical spine manipulation. For the rcSMT the subject's head will be supported by the clinician's forearm. The contact hand of the clinician will contact the C5-C6 spinal segment. A thrust maneuver will be given by the contact hand of the clinician with the supportive hand resting on the subject's zygoma. A rotational inferior drop thrust maneuver will be completed. For the scSMT the subject's head will be rotated to 45 degrees and will be supported by the clinician's forearm, which will lie on top if the headpiece. A thrust maneuver will then be given by the contact hand of the treating clinician to the drop piece with the hand beside the paraspinal musculature simulating a real thrust, the supportive hand will be resting on the subject's zygoma. A inferior drop thrust will be applied to the drop piece (no thrust is made by the contact hand on the cervical spine).
Study NCT01418170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cervical spinal manipulative therapy
Description: A real cervical spine manipulation will be used for the intervention vs a sham cervical spine manipulation. For the rcSMT the subject's head will be supported by the clinician's forearm. The contact hand of the clinician will contact the C5-C6 spinal segment. A thrust maneuver will be given by the contact hand of the clinician with the supportive hand resting on the subject's zygoma. A rotational inferior drop thrust maneuver will be completed. For the scSMT the subject's head will be rotated to 45 degrees and will be supported by the clinician's forearm, which will lie on top if the headpiece. A thrust maneuver will then be given by the contact hand of the treating clinician to the drop piece with the hand beside the paraspinal musculature simulating a real thrust, the supportive hand will be resting on the subject's zygoma. A inferior drop thrust will be applied to the drop piece (no thrust is made by the contact hand on the cervical spine).
Study NCT04286256 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Participants/caregivers will receive several telephone-based and in-person motivational interviewing sessions along with specific oral health recommendations.
Study NCT01370694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-8808
Study NCT01370694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Study NCT01370694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine
Study NCT01370694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisolone
Study NCT01801293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-5806
Study NCT02736799 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham vibrating capsule
Description: Sham device without vibration
Study NCT01197378 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cysteamine Bitartrate Delayed-release Capsules
Description: Participants who entered the trial from the RP103-03 study continued treatment with cysteamine bitartrate every 12 hours at the last dose level prescribed during their participation in that study.~Participants not entering the trial from Study RP103-03 were started on twice a day administration of cysteamine bitartrate at a total daily RP103 dose of 70% of their pre-study total daily stable Cystagon® dose.
Study NCT00833521 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg tablets
Description: 1 x 10 mg
Study NCT00833521 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AMBIEN® 10 mg tablets
Description: 1 x 10 mg
Study NCT02736799 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vibrant Capsule (1 vibration)
Description: 1 vibration/min
Study NCT02736799 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vibrant Capsule (3 vibration)
Description: 3 vibration/min
Study NCT02736799 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vibrant Capsule (5 vibration)
Description: 5 vibration/min
Study NCT03775551 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Improvement cycle
Description: at least 6 workshops (sessions) will be held with the members of the care system, in order to identify opportunities for improvement oriented to the design and application of an innovative intervention based on best practices.
Study NCT03094767 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cardiovascular Rehabilitation
Description: Aerobic and anaerobic exercises performed for 12 weeks, 3x/week, of 60 minutes each.
Study NCT03094767 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Initial and Final assessment
Description: Measuring blood preassure, heart rate, Borg scale, respiratory rate, oxygen saturation and HbA1C in the first day of assessment and after 12 weeks.
Study NCT01392872 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Neuropsychological assessment
Description: This study will evaluate the impact of these treatments on cognitive disabilities, tiredness state, emotion and quality of life in general, on a lengthened period.
Study NCT01367548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Methylnaltrexone (MNTX)
Study NCT01367548 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03857334 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Injection of autologous platelet rich plasma
Study NCT02012101 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: niv plus oxygen therapy
Description: NIV given on Philips Respironics BiPAP Vision apparatus.
Study NCT02012101 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: oxygen therapy
Study NCT01361009 — intervention group
Intervention type: DRUG
Intervention: pramipexole
Description: as prescibed by the investigator
Study NCT04516174 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block using ropivacaine
Description: Before anesthesia, the ultrasound-guided bilateral transversus abdominis plane block using 0.25% ropivacaine was perdormed by anesthesiologist who is not involved in intraoperative management and postoperative follow-up and evaluate the effect after the block completed.
Study NCT04516174 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: After finished the transversus abdominis plane block, then perform tracheal intubation and start the infusion of dexmedetomidine.
Study NCT04516174 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Transversus abdominis plane block using saline
Description: Before anesthesia, the ultrasound-guided bilateral transversus abdominis plane block using saline was perdormed by anesthesiologist who is not involved in intraoperative management and postoperative follow-up and evaluate the effect after the block completed.
Study NCT04516174 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: After finished the transversus abdominis plane block, then perform tracheal intubation and start the infusion of saline, dosage and infusion method of saline are consistent with dexmedetomidine.
Study NCT04031092 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation program
Description: traditional inpatient rehabilitation program.
Study NCT00538291 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cetuximab
Study NCT03857334 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Injection of cortivazol : Altim®
Description: Corticosteroids
Study NCT01560728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy
Description: Individual psychotherapeutic approach occurring once per week for 12 to 20 weeks
Study NCT04129749 — intervention group
Intervention type: PROCEDURE
Intervention: Real-Time Analysis Interactive Lab
Description: The Real-Time Analysis Interactive Lab uses an instrumented treadmill, a motion capture system (Vicon System), an electromyographic system as well as a virtual environment is projected on a 180 ° screen. This equipment allows patients to walk spontaneously or at prescribed speeds to a standstill in a virtual and secure virtual reality environment.
Study NCT01810042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ranibizumab
Description: 0.5mg of ranibizumab is injected into the vitreous cavity through pars plana.
Study NCT03073681 — intervention group
Intervention type: DEVICE
Intervention: Survey
Description: Patients will complete a survey describing their satisfaction with vision after cataract surgery that was performed at least 2 months prior to study enrollment.
Study NCT04453696 — intervention group
Intervention type: BEHAVIORAL
Intervention: Assessment scales-the Spielberger's State-Trait Anxiety Inventory, Modified Dental Anxiety Scale and a visual analog scale.
Description: STAI-S, like kinetic energy, refers to a palpable reaction or process taking place at a given time and level of intensity. STAI-T, like potential energy, refers to individual differences in reactions. Both of STAI-S and STAI-T scales includes 20 questions. For each question, the scores range from 1 (almost never) to 4 (almost always) points. For both scales, the sum of the scores ranges from 20 to 80. A score between 36 and 41 refers to a mean anxiety level, with values greater than 41 classified as a high level of anxiety.~The MDAS consists of 5 questions that measure anxiety at different stages of dental treatment. The options range from 1 (not anxious) to 5 (very anxious) for each question. The sum of the scores varies from 5 to 25; values between 19 and 25 indicate a high level of dental anxiety.~The VAS scale was included in the present study to determine how anxious the patients felt according to their own thoughts. Scores range from 0 (no anxiety) to 10 (extreme anxiety).
Study NCT04829513 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise
Description: This is a home exercise programme that involves flexibility and strengthening of the waist, hip girdle and sacroiliac region. These exercises are first shown by the physiotherapist in hospital, and then they are asked to do the exercises at home using illustrated forms. Patients continue the exercises as a home programme once a day for 1 month.
Study NCT04829513 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ligament Correction Kinesiotaping
Description: Ligament correction kinesiotaping will be applied to the patients' sacroiliac region. Taping will be done once a week. It will be kept for 5 days. This application will be repeated 3 times.
Study NCT04829513 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lymphatic Correction Kinesiotaping
Description: Lymphatic correction kinesiotaping will be applied to the patients' sacroiliac region. Taping will be done once a week. It will be kept for 5 days. This application will be repeated 3 times.
Study NCT02531191 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peficitinib
Description: oral
Study NCT02822443 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological therapy (PT) as TAU with integrated emotion focused components (TAU - EFT)
Description: 25 (+/- 3) weekly sessions and up to three booster sessions of face-to-face outpatient psychotherapy; psychological therapy with focus on emotion-focused interventions.
Study NCT02822443 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological therapy (PT) as TAU with focus on self-regulation (TAU - SR)
Description: 25 (+/- 3) weekly sessions and up to three booster sessions of face-to-face outpatient psychotherapy; psychological therapy with focus on self-regulation without emotion-focused interventions
Study NCT00751530 — intervention group
Intervention type: DRUG
Intervention: raltegravir
Description: New combination ART incorporating raltegravir with other ARVs.
Study NCT03545698 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Avizia Telehealth Platform
Description: Avizia will be utilized as a communication tool between home-based caregivers (family members, formal caregivers, or informal caregivers) and the House Calls care management team.
Study NCT04041076 — intervention group
Intervention type: PROCEDURE
Intervention: Major surgical operation
Description: Surgical operation with magnitude defined as major or ultra-major
Study NCT03725995 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: Patients received 0.5 mg/kg midazolam, with a maximum dose of 10 mg, Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.
Study NCT03725995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine-Midazolam
Description: Patients received a puff of lidocaine 2% in each nostril, after 60 seconds, they received 0.5 mg/kg midazolam, with a maximum dose of 10 mg. , Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.
Study NCT03725995 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients received saline 9% (placebo), 0.5 mg/kg, with a maximum dose of 10 mg, Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.
Study NCT01482741 — intervention group
Intervention type: BEHAVIORAL
Intervention: Focus Group Sessions
Description: Participants will complete a pre-focus group demographic questionnaire. Focus group participants will be asked to report the following: current age; gender; race/ethnicity; income; highest education attained; occupation; and cancer stage if participant has a cancer history. Participants who are parents of pediatric patients will also report their child's current age, gender, and cancer stage. Ten questions will be developed by the investigators and posed to each group by the moderator to solicit the desired information. The objective for the focus groups will be to systematically explore three domains: 1) what participants know about radiation as it relates to medical imaging; 2) how what they know or believe about radiation shapes their attitudes about it; 3) and participant perceptions regarding the availability and adequacy of their sources, including risk-benefit communication with health care providers
Study NCT04031092 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation program
Description: traditional inpatient rehabilitation program.
Study NCT05127694 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation
Description: Vestibular Rehabilitation which is consist of repetitive exercises and canalit repositioning maneuvers
Study NCT01602172 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Alcohol Intervention
Description: 3 part intervention: Part I is 15-minute multi-component motivational discussion in hospital which includes personalized risk feedback, advice to abstain or reduce consumption, and the negotiation of an individual change plan. Part II is 15-minute follow-up in hospital to reinforce Part I. Part III is 15-minute follow-up telephone call at 2 weeks to reinforce Part I.
Study NCT01602172 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle brochures
Description: Set of educational brochures/brochures which contain information and tips for healthy lifestyle behaviors such as alcohol and tobacco use, weight management, and physical activity to discuss with the Research Assistant. Approximately two weeks later, the Research Assistant will call patients in this condition at home for a 5-15 minute session to review the brochures and discuss any questions that s(he) may have.
Study NCT02172677 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Episodic memory task
Study NCT02172677 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fMRI
Study NCT01445418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZ2281 + Carboplatin
Description: Cohort 1: Dose escalation: AZD2281 po bid qd + IV carboplatin D8 of each 21-day cycle.; Cohort 2: Expanded cohort treated at the MTD of the combination identified in Cohort 1.
Study NCT03246217 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Instrumental Music Performance
Description: Participants will play a variety of instruments (acoustic and electronic) to facilitate retraining of everyday functional movements.
Study NCT00643734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: azithromycin sustained release
Description: azithromycin SR 2.0 g by mouth in the form of a slurry for 1 dose
Study NCT00643734 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Description: placebo
Study NCT00643734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: levofloxacin
Description: 500 mg (two 250 mg capsules) by mouth once daily for 7 days
Study NCT04256876 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TTNS
Description: See section 'arms' Stimulation settings: 200 µS, 20 Hz, 1-20 V ( depending of sensory response) Home-therapy: Daily stimulation during 60 minutes.
Study NCT04256876 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: TTNS Sham
Description: See section 'arms'
Study NCT01534910 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aged garlic extract
Description: 2400 mg a day